Alvotech (ALVO.IC)
Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide.
442.00-0.01%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-60.9%
The outlook
Alvotech currently reads as bearish based on below its 50- & 200-day averages, 9% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range9% of the way from its 52-week low to high
Market cap
$149.49B
52-wk high
1,190.00
52-wk low
364.00
50-day avg
444.68
200-day avg
553.46
Trailing P/E
—